Pancreatic Cancer Research

ResearcherAffiliated Hospital of Qingdao UniversityActive in the last 2 years

Ying Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9506-1209; OpenAlex author ID A5100414099. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 2 papers

Papers 3

  1. Smart polymeric nanoparticles for targeted delivery and microenvironment-responsive therapy in pancreatic cancer. Co-author DOI 10.1016/j.smaim.2025.09.003↗
  2. Modulating immune cells within pancreatic ductal adenocarcinoma via nanomedicine. First author DOI 10.1042/ebc20243001↗
  3. Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective. Co-author DOI 10.3389/fonc.2023.1166860↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jingjing Sun · 2 shared papers, 2025 · strength 0.71
  2. Junyi Lin · 2 shared papers, 2025 · strength 0.71
  3. Narayani Prasad Kar · 1 shared paper, 2025 · strength 0.28
  4. Jing Wang · 1 shared paper, 2023 · strength 0.22
  5. Shanglong Liu · 1 shared paper, 2023 · strength 0.22
  6. Hanxiang Zhan · 1 shared paper, 2023 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.